To decrease the rate of combined endpoint of CV(Cardio-Vascular) death, myocardial infarction (MI), stroke, or refractory ischemia in patients with non-ST-segment elevation ACS (Acute Coronary Syndromes).
Administration/Dosage
MI/Stroke/Peripheral Arterial Disease : 75mg qd.
ACS : initially administrated 300mg and 75mg qd. as maintenance dose.
Active Ingredient/Content
Clopidogrel Bisulfate 97.87mg (Clopidogrel 75mg)
Efficacy/Indication
To decrease the rate of combined endpoint of CV(Cardio-Vascular) death, myocardial infarction (MI), stroke, or refractory ischemia in patients with non-ST-segment elevation ACS (Acute Coronary Syndromes).
Administration/Dosage
MI/Stroke/Peripheral Arterial Disease : 75mg qd.
ACS : initially administrated 300mg and 75mg qd. as maintenance dose.